India bolsters clinical trial monitoring system
This article was originally published in SRA
Executive Summary
India is continuing to strengthen its regulatory monitoring mechanism for drug clinical trials as part of efforts to ensure standardized practices in the segment and protect the safety and rights of trial participants1.